# PKIA

## Overview
The PKIA gene encodes the protein cAMP-dependent protein kinase inhibitor alpha (PKIa), which is a key regulatory protein involved in the modulation of cAMP-dependent protein kinase (PKA) activity. PKIa is categorized as an intrinsically disordered protein, characterized by its lack of a stable tertiary structure, which allows it to interact dynamically with its target, the catalytic subunit of PKA (PKA-C). This interaction is crucial for inhibiting PKA-C activity, thereby regulating various cellular processes such as metabolism, gene expression, and cell cycle progression (Olivieri2020Multistate; Dalton2006Protein). PKIa contains functional motifs, including a high-affinity region and a nuclear export signal, which are essential for its inhibitory function and subcellular localization (Hauer1999Two). The protein plays significant roles in the nervous system and developmental processes, and its dysregulation has been implicated in several cancers, highlighting its clinical significance (Hoy2020Protein; Dalton2006Protein).

## Structure
The protein kinase inhibitor alpha (PKIa) is an intrinsically disordered protein that plays a crucial role in inhibiting the catalytic subunit of cAMP-dependent protein kinase A (PKA-C). Its primary structure includes several functional motifs: a high-affinity region (HAR), a pseudo-substrate sequence (PSS), a nuclear export signal (NES), and a disordered C-terminal tail (Olivieri2020Multistate). The HAR and NES motifs are particularly important for binding and nuclear export functions, respectively (Hauer1999Two).

In terms of secondary structure, PKIa contains two alpha-helical regions. Helix I extends from residues 1 to 13 and is involved in high-affinity binding to the kinase. Helix II, spanning residues 34 to 44, overlaps with the NES and is crucial for nuclear export (Hauer1999Two). Despite these structured regions, PKIa is largely unstructured in solution, exhibiting a dynamic equilibrium between structured and less structured states (Hauer1999Two).

The tertiary structure of PKIa is characterized by transient secondary structures and short-lived tertiary interactions, as revealed by NMR and paramagnetic relaxation enhancement experiments (Olivieri2020Multistate). The protein does not form a stable quaternary structure, as it functions primarily as a monomer in its role as an inhibitor.

## Function
The PKIA gene encodes the cAMP-dependent protein kinase inhibitor alpha, which plays a crucial role in regulating the activity of cAMP-dependent protein kinase (PKA) in healthy human cells. PKIA functions by binding to the catalytic subunit of PKA, effectively inhibiting its activity. This inhibition is essential for controlling various cellular processes, including metabolism, gene expression, and cell cycle progression (Dalton2006Protein).

PKIA contains two distinct functional domains: a pseudosubstrate site that contributes to its potent inhibitory activity and a leucine-rich nuclear export signal (NES). The NES facilitates the transport of the catalytic subunit from the nucleus to the cytoplasm, ensuring proper localization and regulation of PKA activity (Dalton2006Protein). The protein is primarily active in the cytoplasm and nucleus, where it influences signal transduction pathways (Dalton2006Protein).

In the nervous system, PKIA modulates synaptic activity and is involved in long-term potentiation in hippocampal neurons. It plays a role in morphogenesis and the formation of the symmetrical left-right axis during vertebrate embryogenesis, highlighting its importance in developmental processes (Dalton2006Protein).

## Clinical Significance
Alterations in the expression of the PKIA gene have been implicated in various cancers. PKIA overexpression is associated with enhanced ERK activation and altered cAMP signaling, contributing to tumor growth and progression. In prostate cancer, PKIA gene amplifications are frequent and linked to aggressive cancer phenotypes, with a significant reduction in progression-free survival observed in patients with these alterations (Hoy2020Protein). Elevated PKIA mRNA levels are particularly noted in castration-resistant prostate cancer cell lines, suggesting a role in cancer metastasis and growth (Hoy2020Protein).

In lung adenocarcinoma, the methylation status of PKIA is being explored as a potential biomarker. A negative correlation between PKIA methylation and expression levels has been observed, indicating that methylation may regulate its expression. This relationship suggests that PKIA could serve as a prognostic biomarker for lung cancer (Xu2023Exploring).

In hepatocellular carcinoma, PKIA expression is associated with DNA methylation rather than genetic alterations. Its expression correlates with immune cell infiltration, which is linked to a worse prognosis, highlighting its potential role in cancer progression (Li2022Comprehensive).

## Interactions
PKIA, also known as cAMP-dependent protein kinase inhibitor alpha, interacts primarily with the catalytic subunit of protein kinase A (PKA-C). This interaction is crucial for inhibiting the activity of PKA-C, which is in a constitutively active state when not bound to its regulatory subunit. PKIA contains small linear motifs (SLiMs) that bind with high affinity to the substrate binding site of PKA-C, effectively trapping it in an inactive state (Olivieri2020Multistate). The binding process involves an initial fast step where PKA-C selects the most competent conformations of PKIA, followed by a slower conformational rearrangement, which increases the helicity of the high affinity region (HAR) and nuclear export signal (NES) motifs of PKIA (Olivieri2020Multistate).

PKIA also plays a role in the nuclear export of PKA-C. The NES motif of PKIA is crucial for binding to the nuclear export machinery CRM1/RanGTP, which regulates cell proliferation by exporting the enzyme out of the nucleus (Olivieri2020Multistate). This interaction highlights the dual role of PKIA in both inhibiting PKA-C activity and facilitating its nuclear export, demonstrating its importance in regulating kinase signaling pathways.


## References


[1. (Li2022Comprehensive) Gaopeng Li, Zhuangqiang Wang, Dong Chen, Jun Yin, Zhiyuan Mo, Bianyin Sun, Tao Yang, Xinning Zhang, Zhensheng Zhai, Yaoxuan Li, Pinggui Chen, Yunyan Dai, Zhiming Wang, and Jun Ma. Comprehensive analysis of a tpx2-related trhde-as1/pkia cerna network involving prognostic signatures in hepatitis b virus-infected hepatocellular carcinoma. Frontiers in Cellular and Infection Microbiology, September 2022. URL: http://dx.doi.org/10.3389/fcimb.2022.1025900, doi:10.3389/fcimb.2022.1025900. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcimb.2022.1025900)

[2. (Xu2023Exploring) Bowen Xu, Jingang Zhang, Weigang Chen, and Wei Cai. Exploring the methylation status of cftr and pkia genes as potential biomarkers for lung adenocarcinoma. Orphanet Journal of Rare Diseases, August 2023. URL: http://dx.doi.org/10.1186/s13023-023-02807-1, doi:10.1186/s13023-023-02807-1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-023-02807-1)

[3. (Hoy2020Protein) James J. Hoy, Natalia Salinas Parra, Jeannie Park, Skyler Kuhn, and Ramiro Iglesias‐Bartolome. Protein kinase a inhibitor proteins (pkis) divert gpcr‐gαs‐camp signaling toward epac and erk activation and are involved in tumor growth. The FASEB Journal, 34(10):13900–13917, August 2020. URL: http://dx.doi.org/10.1096/fj.202001515r, doi:10.1096/fj.202001515r. This article has 30 citations.](https://doi.org/10.1096/fj.202001515r)

[4. (Hauer1999Two) Jennifer A. Hauer, Philippe Barthe, Susan S. Taylor, Joseph Parello, and André Padilla. Two well‐defined motifs in the camp‐dependent protein kinase inhibitor (pkiα) correlate with inhibitory and nuclear export function. Protein Science, 8(3):545–553, January 1999. URL: http://dx.doi.org/10.1110/ps.8.3.545, doi:10.1110/ps.8.3.545. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1110/ps.8.3.545)

[5. (Olivieri2020Multistate) Cristina Olivieri, Yingjie Wang, Geoffrey C Li, Manu V S, Jonggul Kim, Benjamin R Stultz, Matthew Neibergall, Fernando Porcelli, Joseph M Muretta, David DT Thomas, Jiali Gao, Donald K Blumenthal, Susan S Taylor, and Gianluigi Veglia. Multi-state recognition pathway of the intrinsically disordered protein kinase inhibitor by protein kinase a. eLife, April 2020. URL: http://dx.doi.org/10.7554/elife.55607, doi:10.7554/elife.55607. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.55607)

[6. (Dalton2006Protein) George D. Dalton and William L. Dewey. Protein kinase inhibitor peptide (pki): a family of endogenous neuropeptides that modulate neuronal camp-dependent protein kinase function. Neuropeptides, 40(1):23–34, February 2006. URL: http://dx.doi.org/10.1016/j.npep.2005.10.002, doi:10.1016/j.npep.2005.10.002. This article has 117 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.npep.2005.10.002)